BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sudo T, Iwaya T, Nishida N, Sawada G, Takahashi Y, Ishibashi M, Shibata K, Fujita H, Shirouzu K, Mori M. Expression of mesenchymal markers vimentin and fibronectin: the clinical significance in esophageal squamous cell carcinoma. Ann Surg Oncol. 2013;20 Suppl 3:S324-S335. [PMID: 22644514 DOI: 10.1245/s10434-012-2418-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Haga H, Patel T. Molecular diagnosis of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2015;22:114-23. [PMID: 25267595 DOI: 10.1002/jhbp.156] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
2 Kim S, Lee J, Jeon M, Lee JE, Nam SJ. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway. Oncotarget 2016;7:1544-58. [PMID: 26637807 DOI: 10.18632/oncotarget.6441] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
3 Zhu Y, Clair G, Chrisler WB, Shen Y, Zhao R, Shukla AK, Moore RJ, Misra RS, Pryhuber GS, Smith RD, Ansong C, Kelly RT. Proteomic Analysis of Single Mammalian Cells Enabled by Microfluidic Nanodroplet Sample Preparation and Ultrasensitive NanoLC-MS. Angew Chem 2018;130:12550-4. [DOI: 10.1002/ange.201802843] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
4 Luo L, Wang C, Song X, Wang H, Zhou H, Sun Y, Wang X, Hou S, Pei F. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. Biomedicine & Pharmacotherapy 2018;105:841-7. [DOI: 10.1016/j.biopha.2018.03.058] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
5 Hwang CC, Nieh S, Lai CH, Tsai CS, Chang LC, Hua CC, Chi WY, Chien HP, Wang CW, Chan SC, Hsieh TY, Chen JR. A retrospective review of the prognostic value of ALDH-1, Bmi-1 and Nanog stem cell markers in esophageal squamous cell carcinoma. PLoS One 2014;9:e105676. [PMID: 25148045 DOI: 10.1371/journal.pone.0105676] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
6 Iguchi T, Ueda M, Masuda T, Nambara S, Kidogami S, Komatsu H, Sato K, Tobo T, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K. Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma. Oncology 2018;95:179-87. [PMID: 29909415 DOI: 10.1159/000488860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhao Y, Zhu J, Shi B, Wang X, Lu Q, Li C, Chen H. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2019;38:304. [PMID: 31296250 DOI: 10.1186/s13046-019-1296-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lo LM, Raghunath M, Lee KKH. Growing Human Dermal Fibroblasts as Spheroids Renders Them Susceptible for Early Expression of Pluripotency Genes. Adv Biosys 2019;3:1900094. [DOI: 10.1002/adbi.201900094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang C, Yan F, Zhang J, Huang H, Cui Q, Dong W, Zhang W, Zhao Y, Chen H, Zhao T. OV6 + cancer stem cells drive esophageal squamous cell carcinoma progression through ATG7-dependent β-catenin stabilization. Cancer Letters 2017;391:100-13. [DOI: 10.1016/j.canlet.2017.01.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gao Z, Lu C, Wang Z, Song Y, Zhu J, Gao P, Sun J, Chen X, Wang M, Dong Y, Xu H. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer. Histopathology 2014;65:527-38. [DOI: 10.1111/his.12435] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
11 Desaki R, Sawada G, Okumura H, Ikeda R, Tanabe K, Komatsu H, Mimori K, Mori M, Kita Y, Uchikado Y, Arigami T, Uenosono Y, Owaki T, Ishigami S, Natsugoe S. As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2017;24:586-93. [PMID: 26676980 DOI: 10.1245/s10434-015-5031-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Zhao Y, Lu Q, Li C, Wang X, Jiang L, Huang L, Wang C, Chen H. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation. Cell Death Dis 2019;10:359. [PMID: 31043582 DOI: 10.1038/s41419-019-1595-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
13 汤朝晖, 吕立升, 林培艺, 陈志升, 全志伟. 从肿瘤异质性看肝内胆管癌的细胞起源. 世界华人消化杂志 2015; 23(33): 5255-5262 [DOI: 10.11569/wcjd.v23.i33.5255] [Reference Citation Analysis]
14 Adam RS, Blomberg I, Ten Hoorn S, Bijlsma MF, Vermeulen L. The recurring features of molecular subtypes in distinct gastrointestinal malignancies-A systematic review. Crit Rev Oncol Hematol 2021;164:103428. [PMID: 34284100 DOI: 10.1016/j.critrevonc.2021.103428] [Reference Citation Analysis]
15 Jeon M, Lee J, Nam SJ, Shin I, Lee JE, Kim S. Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells. Exp Cell Res 2015;333:116-26. [PMID: 25743092 DOI: 10.1016/j.yexcr.2015.02.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
16 Chang HY, Lee CH, Li YS, Huang JT, Lan SH, Wang YF, Lai WW, Wang YC, Lin YJ, Liu HS, Cheng HC. MicroRNA-146a suppresses tumor malignancy via targeting vimentin in esophageal squamous cell carcinoma cells with lower fibronectin membrane assembly. J Biomed Sci. 2020;27:102. [PMID: 33248456 DOI: 10.1186/s12929-020-00693-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Zhou Y, Shu C, Huang Y. Fibronectin promotes cervical cancer tumorigenesis through activating FAK signaling pathway. J Cell Biochem 2019. [PMID: 30977220 DOI: 10.1002/jcb.28282] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
18 Li F, Zhang Z, Wang P, Wen P, Xu Q, Wang Y, Pan P, Ma L. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway. Life Sci 2019;232:116679. [PMID: 31340168 DOI: 10.1016/j.lfs.2019.116679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
19 Brzozowa M, Wyrobiec G, Kołodziej I, Sitarski M, Matysiak N, Reichman-Warmusz E, Żaba M, Wojnicz R. The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract. Prz Gastroenterol 2015;10:7-11. [PMID: 25960808 DOI: 10.5114/pg.2014.47502] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
20 Chang H, Lee C, Li Y, Huang J, Lan S, Wang Y, Lai W, Wang Y, Lin Y, Liu H, Cheng H. MicroRNA-146a suppresses tumor malignancy via targeting vimentin in esophageal squamous cell carcinoma cells with lower fibronectin membrane assembly. J Biomed Sci 2020;27. [DOI: 10.1186/s12929-020-00693-4] [Reference Citation Analysis]
21 Wang W, Ji HJ, Sun NB, Chang XT, Xu B, Wang Y, Cao M, Zhu Q, Zang Q, Jiang ZM. B-cell specific Moloney leukemia virus insert site 1 and peptidyl arginine deiminase IV positively regulate carcinogenesis and progression of esophageal squamous cell carcinoma. Oncol Lett 2017;13:4349-56. [PMID: 28599437 DOI: 10.3892/ol.2017.6001] [Reference Citation Analysis]
22 Palumbo A Jr, Meireles Da Costa N, Pontes B, Leite de Oliveira F, Lohan Codeço M, Ribeiro Pinto LF, Nasciutti LE. Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix. Cells 2020;9:E455. [PMID: 32079295 DOI: 10.3390/cells9020455] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
23 Zhao Y, Feng C, Li Y, Ma Y, Cai R. LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function. Mol Cell Biochem 2019;460:1-8. [PMID: 31187349 DOI: 10.1007/s11010-019-03564-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
24 Zhang LY, Liu M, Li X, Tang H. miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). J Biol Chem. 2013;288:4035-4047. [PMID: 23212913 DOI: 10.1074/jbc.m112.410506] [Cited by in Crossref: 102] [Cited by in F6Publishing: 74] [Article Influence: 11.3] [Reference Citation Analysis]
25 Niwa Y, Yamada S, Koike M, Kanda M, Fujii T, Nakayama G, Sugimoto H, Nomoto S, Fujiwara M, Kodera Y. Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2014;110:764-769. [PMID: 24975035 DOI: 10.1002/jso.23694] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
26 Zhang C, Li R, Qi Y, Li X, Yang Y, Liu D, Zhao J, Zhu D, Wu K, Zhou X, Zhao S. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial–mesenchymal transition. Cell Biol Toxicol 2016;32:391-401. [DOI: 10.1007/s10565-016-9341-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
27 Song X, Kong J, Song J, Pan R, Wang L. Angelica sinensis Polysaccharide Alleviates Myocardial Fibrosis and Oxidative Stress in the Heart of Hypertensive Rats. Comput Math Methods Med 2021;2021:6710006. [PMID: 34527077 DOI: 10.1155/2021/6710006] [Reference Citation Analysis]
28 Xiao J, Yang W, Xu B, Zhu H, Zou J, Su C, Rong J, Wang T, Chen Z. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration. BMC Cancer 2018;18:976. [PMID: 30314454 DOI: 10.1186/s12885-018-4850-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
29 Tanaka M, Kijima H, Shimada H, Makuuchi H, Ozawa S, Inokuchi S. Expression of podoplanin and vimentin is correlated with prognosis in esophageal squamous cell carcinoma. Mol Med Rep. 2015;12:4029-4036. [PMID: 26095281 DOI: 10.3892/mmr.2015.3966] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
30 Morita Y, Hata K, Nakanishi M, Omata T, Morita N, Yura Y, Nishimura R, Yoneda T. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma. Clin Exp Metastasis 2015;32:739-53. [PMID: 26319373 DOI: 10.1007/s10585-015-9741-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
31 Aghamollaei H, Parvin S, Shahriary A. Review of proteomics approach to eye diseases affecting the anterior segment. J Proteomics 2020;225:103881. [PMID: 32565161 DOI: 10.1016/j.jprot.2020.103881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Zhu Y, Clair G, Chrisler WB, Shen Y, Zhao R, Shukla AK, Moore RJ, Misra RS, Pryhuber GS, Smith RD, Ansong C, Kelly RT. Proteomic Analysis of Single Mammalian Cells Enabled by Microfluidic Nanodroplet Sample Preparation and Ultrasensitive NanoLC-MS. Angew Chem Int Ed Engl 2018;57:12370-4. [PMID: 29797682 DOI: 10.1002/anie.201802843] [Cited by in Crossref: 86] [Cited by in F6Publishing: 72] [Article Influence: 28.7] [Reference Citation Analysis]